Related Articles
Reversal of multidrug resistance by the anti‑malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line
Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate
Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo
Increasing the antioxidant defense in WEHI7.2 cells results in a more tumor-like metabolic profile
The anti-malarial artesunate is also active against cancer